S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 1157-1163

  Daelemans, Dirk ^a   Esté, Jose A ^a   Witvrouw, Myriam ^a   Pannecouque, Christophe ^a   Jonckheere, Heidi ^a   Aquaro, Stefano ^b   Perno, Carlo Federico ^b   De Clercq, Erik ^a   Vandamme, Anne Mieke ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZA 3 CHLOROADENOSINE; 3 DEAZA 3 FLUOROADENOSINE; 3 DEAZAADENOSINE; 3 DEAZAARISTEROMYCIN; 3 DEAZANEPLANOCIN A; 7 CHLORO 1,3 DIHYDRO 5 (2 PYRROLYL) 2H 1,4 BENZODIAZEPIN 2 ONE; 9 (2,3 DIHYDROXYCYCLOPENTYL) 3 DEAZAADENINE; 9 (2,3 DIHYDROXYCYCLOPENTYL) 7 DEAZAADENINE; 9 (2,3 DIHYDROXYCYCLOPENTYL)ADENINE; 9 (2,3 DIHYDROXYPROPYL)ADENINE; ADENOSINE DERIVATIVE; ADENOSYLHOMOCYSTEINASE; ENZYME INHIBITOR; KS 605; KS 606; NKO 6163; NOM 1461; SAQUINAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG STRUCTURE; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0031439586     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.1157     Document Type: Article

References (39)

1. de la Haba, G., and G. L Cantoni. The enzymatic synthesis of S-adenosylhomocysteine from adenosine and homocysteine. J. Biol. Chem. 294:603-608 (1959).
2. Borchardt, R. T. S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for design of chemotherapeutic agents. J. Med. Chem. 23:347-357 (1980).
3. De Clercq, E. S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem. Pharmacol. 36:2567-2575 (1987).
4. De Clercq, E., M. Cools, J. Balzarini, V. E. Marquez, D. R. Borcherding, R. T. Borchardt, J. C. Drach, S. Kitaoka, and T. Konno. Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives. Antimicrob. Agents Chemother. 33:1291-1297 (1989).
5. De Clercq, E. Antiviral activity spectrum and target of action of different classes of nucleoside analogues. Nucleosides Nucleotides 13:1271-1295 (1994).
6. Snoeck, R., G. Andrei, J. Neyts, D. Schols, M. Cools, J. Balzarini, and E. De Clercq. Inhibitory activity of S-adenosylhomocysteine hydrolase inhibitors against human cytomegalovirus replication. Antiviral Res. 21:197-216 (1993).
7. Cools, M., and E. De Clercq. Correlation between the antiviral activity of acyclic and carbocyclic adenosine analogues and their inhibitory effect on L929 cell S-adenosylhomocysteine hydrolase. Biochem. Pharmacol. 38: 1061-1067 (1989).
8. Franchetti, P., L. Cappellacci, G. Cristalli, M. Grifantini, A. Pani, P. La Colle, and G. Nocentini. Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2′,3′-didehydro-2′,3′-dideoxy-3-deazaadenosine, 2′,3′-dideoxy-3-deazaadenosine and some 2′,3′-dideoxy-3-deazaadenosine 5′-dialkyl phosphates. Nucleosides Nucleotides 10:1551-1562 (1991).
9. Flexner, C. W., J. E. Hildreth, R. W. Kuncl, and D. B. Drachman. 3-Deazaadenosine and inhibition of HIV. Lancet 339:438 (1992).
10. Mayers, D. L., J. A. Mikovits, B. Joshi, I. K. Hewlett, J. S. Estrada, A. D. Wolfe, G. E. Garcia, B. P. Doctor, D. S. Burke, R. K. Gordon, J. R. Lane, and P. Chiang. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogues: increased potency against 3′-azido-3′-deoxythymidine-resistant HIV-1 strains. Proc. Natl. Acad. Sci. USA 92: 215-219 (1995).
11. Arya, S. K., C. Guo, S. F. Josephs, and F. Wong-Staal. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science (Washington D. C.) 229:69-73 (1985).
12. Berkhout, B., R. H. Silverman, and K. T. Jeang. Tat transactivates the immunodeficiency virus through a nascent RNA target. Cell 59:273-282 (1989).
13. Feng, S., and E. C. Holland. HIV-1 Tat trans-activation requires the loop sequence within TAR. Nature (Lond.) 334:165-167 (1988).
14. Garcia, J. A., D. Harrich, E. Soultanakis, F. Wu, H. Mitsuya, and R. B. Gaynor. Human immunodeficiency virus type 1 LTR TAT and TAR region sequences required for transcription regulation. EMBO J. 8:765-778 (1989).
15. Hauber, J., and B. R. Cullen. Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 62:673-679 (1988).
16. Rosen, C. A., J. G. Sodroski, and W. A. Haseltine. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823 (1985).
17. Sodroski, J., C. A. Rosen, F. Wong-Staal, S. Z. Salahuddin, M. Popovic, S. Arya, R. C. Gallo, and W. A. Haseltine. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science (Washington D. C.) 227:171-173 (1985).
18. Hsu, M.-C., D. Schutt, M. Holly, L. W. Slice, M. I. Sherman, D. D. Richman, M. J. Potash, and D. J. Volsky. Inhibition of HIV replication in acute and chronic infections in vitro by a tat antagonist. Science (Washington D. C.) 254:1799-1802 (1991).
19. Witvrouw, M., R. Pauwels, A.-M. Vandamme, D. Schols, D. Reymen, N. Yamamoto, J. Desmyter, and E. De Clercq. Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335. Antimicrob. Agents Chemother. 36:2628-2633 (1992).
20. Rosen, C. A., J. G. Sodroski, K. Campbell, and W. A. Haseltine. Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes. J. Virol. 57:379-384 (1985).
21. Maio, J. J., and F. L. Brown. Regulation of expression driven by human immunodeficiency virus type 1 and human T-cell leukemia virus type I long terminal repeats in pluripotential human embryonic cells. J. Virol. 62:1398-1407 (1988).
22. Berger, J., J. Hauber, R. Hauber, R. Geiger, and B. Cullen. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1-10 (1988).
23. Clavel, F., and P. Chameau. Fusion from without directed by human immunodeficiency particles. J. Virol. 68:1179-1185 (1994).
24. Sambrook, J., E. F. Fritsch, and T. Maniatis. Expression of cloned genes in cultured mammalian cells, in Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
25. Hershfield, M. S., V. N. Aiyar, R. Premakumar, and W. C. Small. S-Adenosylhomocysteine hydrolase from human placenta: affinity purification and characterisation. Biochen. J. 230:43-52.
26. Pauwels, R., E. De Clercq, J. Desmyter, J. Balzarini, P. Goubau, P. Herdewijn, H. Vanderhaeghe, and M. Vandeputte. Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus. J. Virol. Methods 16:171-185 (1987).
27. Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. De Clercq. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321 (1988).
28. Reed, L. J., and H. Muench. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497 (1938).
29. Perno, C. F., A. Bergamini, C. D. Pesce, G. Milanese, M. Capozzi, S. Aquaro, S. Thaisrivongs, W. G. Tarpley, G. Zon, C. D'Agostini, G. Rocchi, E. Garaci, and R. Calió. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically-infected macrophages. J. Infect. Dis. 168:1148-1156 (1993).
30. Perno, C. F., and R. Yarchoan. Culture of HIV in monocytes and macrophages, in J. E. Coligan, A. H. Kruisbeck, D. H. Margulies, E. M. Sherwach, W. Strober, editors. Current Protocols in Immunology. Wiley, New York, 12.4.1-12.4.11 (1993).
31. Jonckheere, H., K De Vreese, Z. Debyser, J. Vanderkerckhove, J. Balzarini, J. Desmyter, E. De Clercq, and J. Anné. A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1. J. Virol. Methods 61:113-125 (1996).
32. Perno, C. F., S. Aquaro, B. Rosenwirth, E. Balestra, P. Peichl, A. Billich, N. Villani, and R. Calió. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J. Leuk. Biol. 56:381-386 (1994).
33. Newstein, M., E. J. Stanbridge, G. Casey, and P. R. Shank. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 Tat-mediated transactivation in rodent cells. J. Virol. 64:4565-4567 (1990).
34. Gaynor, R. Cellular transcription factors involved in the regulation of HTV-1 gene expression. AIDS 6:347-363 (1992).
35. Kingsman, S. M, and A. J. Kingsman. The regulation of human immunodeficiency virus type-1 gene expression. Eur. J. Biochem. 240:491-507 (1996).
36. Ueland, P. M. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev. 34: 223-253 (1982).
37. Chiang, P. K, and G. A. Miura. S-Adenosylhomocysteine hydrolase, in Biological Methylation and Drug Design (R. T. Borchardt, C. R. Creveling, and P. M. Ueland, eds.). Humana Press, Clifton, NJ, 239-251 (1986).
38. Bennett, L. L., Jr., R. W. Brockman, P. W. Allan, L. M. Rose, and S. C. Shaddix. Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds: role of adenylate deaminase. Biochem. Pharmacol. 37:1233-1244 (1988).
39. Prus, K. L., G. Wolberg, P. M. Keller, J. A. Fyfe, C. R. Stopford, and T. P. Zimmerman. 3-Deazaadenosine 5′-triphosphate: a novel metabolite of 3-deazaadenosine in mouse leukocytes. Biochem. Pharmacol. 38:509-517 (1989).